Global Innovative Platforms (GIPL) Cash & Equivalents Growth (5y) (2026)
Analysis
Global Innovative Platforms (GIPL) Cash & Equivalents Growth (5y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.46 Bn | 40.26 Bn | 779.09 Mn |
| 2 | Zoetis | 30.65 Bn | 28.98 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.29 Mn | 68.19 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |